Neurology Group of Bergen County, P.A.
Quick facts
Marketed products
- Guanfacine (sustained release) · Neurology / Psychiatry
Guanfacine is an alpha-2A adrenergic receptor agonist that reduces norepinephrine activity in the prefrontal cortex to improve attention and impulse control.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Neurology Group of Bergen County, P.A. portfolio CI brief
- Neurology Group of Bergen County, P.A. pipeline updates RSS
Frequently asked questions about Neurology Group of Bergen County, P.A.
What are Neurology Group of Bergen County, P.A.'s marketed drugs?
Top marketed products include Guanfacine (sustained release).
Related
- Guanfacine (sustained release) · Neurology / Psychiatry
- Sector hub: All tracked pharma companies